Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sophia Nozick"'
Autor:
Giancarlo Atassi, Rachel Medernach, Marc Scheetz, Sophia Nozick, Nathaniel J. Rhodes, Megan Murphy-Belcaster, Katherine R. Murphy, Arghavan Alisoltani, Egon A. Ozer, Alan R. Hauser
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Pseudomonas aeruginosa frequently becomes resistant to aminoglycosides by the acquisition of aminoglycoside modifying enzyme (AME) genes and the occurrence of mutations in the mexZ, fusA1, parRS, and armZ genes. We examined resistance to ami
Externí odkaz:
https://doaj.org/article/106b4f8e66be4fb681ebc4a84ed2e1a1
Autor:
Natalie S Haddad, Sophia Nozick, Shant Ohanian, Robert Smith, Susan Elias, Paul G Auwaerter, F Eun-Hyung Lee, John L Daiss
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0293203 (2023)
BackgroundDiagnostic immunoassays for Lyme disease have several limitations including: 1) not all patients seroconvert; 2) seroconversion occurs later than symptom onset; and 3) serum antibody levels remain elevated long after resolution of the infec
Externí odkaz:
https://doaj.org/article/10fe42c238e04da0917e2b263abc8b55
Publikováno v:
Open Forum Infectious Diseases. 9
Background P. aeruginosa is a cause of hospital-acquired and ventilator-associated pneumonia. Hypermutator P. aeruginosa strains have been described in patients with cystic fibrosis and chronic respiratory infections but are rare in patients with acu
Autor:
Rachel Medernach, William J Moore, Sophia Nozick, Maha M Alamri, Kendall Kling, Michael G Ison, Qi Chao, Kelly E R Bachta, Nathaniel J Rhodes, Egon A Ozer, Alan R Hauser
Publikováno v:
Open Forum Infectious Diseases. 9
Background Cefiderocol (FDC) is a novel antimicrobial agent used for multi-drug resistant Gram-negative pathogens. To date, reports of mutations in β-lactamase and siderophore complex genes have been described and may contribute to FDC resistance. T
Autor:
Natalie S. Haddad, Sophia Nozick, Geena Kim, Shant Ohanian, Colleen S. Kraft, Paulina A. Rebolledo, Yun Wang, Hao Wu, Adam Bressler, Sang Nguyet Thi Le, Merin Kuruvilla, Martin C. Runnstrom, Richard P. Ramonell, L. Edward Cannon, F. Eun-Hyung Lee, John L. Daiss
Publikováno v:
J Clin Microbiol
Within 8 weeks of primary Clostridioides difficile infection (CDI), as many as 30% of patients develop recurrent disease with the associated risks of multiple relapses, morbidity, and economic burden. There are no clear clinical correlates or validat
Autor:
F. Eun-Hyung Lee, Natalie S. Haddad, John L. Daiss, Hao Wu, Sang Nguyet Thi Le, Adam Bressler, L. Edward Cannon, Shant Ohanian, Sophia Nozick, Colleen S. Kraft, Geena Kim, Yun F. Wang, Merin Kuruvilla, Paulina A. Rebolledo
BackgroundWithin eight weeks of primary Clostridioides difficile infection (CDI), as many as 30% of patients develop recurrent disease with the associated risks of multiple relapses, morbidity, and economic burden. There are no validated biomarkers p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a99156b66ae38cda9bc43354c22e2c8e
https://doi.org/10.1101/2021.11.04.21265901
https://doi.org/10.1101/2021.11.04.21265901
Autor:
Egon A. Ozer, Sophia Nozick, Katherine R. Murphy, Alan R. Hauser, Nathaniel J. Rhodes, Giancarlo Atassi, Marc H. Scheetz, Megan Murphy-Belcaster
Pseudomonas aeruginosa is a frequent cause of antibiotic-resistant infections. Although P. aeruginosa is intrinsically resistant to many antimicrobial agents, aminoglycosides are active against this organism in the absence of acquired resistance dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9e7dc50228f63e48f7a15da58e31bbb
https://doi.org/10.1101/2021.01.15.21249897
https://doi.org/10.1101/2021.01.15.21249897
Autor:
Paulina A. Rebolledo, Sang Nguyet Thi Le, Colleen S. Kraft, Geena Kim, Hao Wu, Yun F. Wang, Merin Kuruvilla, Adam Bressler, F. Eun-Hyung Lee, John L. Daiss, Natalie S. Haddad, Shant Ohanian, Sophia Nozick, L. Edward Cannon
Publikováno v:
Journal of immunological methods. 492
BACKGROUNDClostridioides difficile infections (CDI) have been a challenging and increasing serious concern in recent years. While early and accurate diagnosis is crucial, available assays have frustrating limitationsOBJECTIVEDevelop a simple, blood-b